Page last updated: 2024-09-05

erlotinib hydrochloride and phenylalanine

erlotinib hydrochloride has been researched along with phenylalanine in 3 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (phenylalanine)	Trials (phenylalanine)	Recent Studies (post-2010) (phenylalanine)
4,353	786	3,033	23,695	721	4,367

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armstrong, C; Durkin, AJ; Osborne, DA; Rosemurgy, AS; Yeatman, TJ; Zervos, EE	1
Fu, X; Ho, WT; Ishii, T; Li, Q; Li, Z; Xing, S; Xu, M; Zhao, ZJ	1
Al-Kali, A; Cherry, M; Ghabache, B; Khawandanah, M; Ozer, H; Selby, G; Srour, S; Zhao, ZJ	1

Trials

1 trial(s) available for erlotinib hydrochloride and phenylalanine

Article	Year
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera. Annals of hematology, 2015, Volume: 94, Issue:4 Topics: Adult; Aged; Amino Acid Substitution; Antineoplastic Agents; Drug-Related Side Effects and Adverse Reactions; Erlotinib Hydrochloride; Female; Humans; Janus Kinase 2; Male; Middle Aged; Phenylalanine; Polycythemia Vera; Quinazolines; Treatment Outcome; Valine	2015

Other Studies

2 other study(ies) available for erlotinib hydrochloride and phenylalanine

Article	Year
EGF receptor antagonism improves survival in a murine model of pancreatic adenocarcinoma. The Journal of surgical research, 2006, Volume: 135, Issue:1 Topics: Adenocarcinoma; Animals; Cell Division; Cell Line, Tumor; Disease Models, Animal; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Protein Kinase Inhibitors; Quinazolines; Survival Rate; Thiophenes	2006
Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth. The Journal of biological chemistry, 2007, Feb-09, Volume: 282, Issue:6 Topics: Amino Acid Substitution; Animals; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Enzyme Activation; Erlotinib Hydrochloride; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Janus Kinase 2; Jurkat Cells; Mice; Phenylalanine; Polycythemia Vera; Protein Kinase Inhibitors; Quinazolines; Valine	2007

Article

Year

EGF receptor antagonism improves survival in a murine model of pancreatic adenocarcinoma.

The Journal of surgical research, 2006, Volume: 135, Issue:1

Topics: Adenocarcinoma; Animals; Cell Division; Cell Line, Tumor; Disease Models, Animal; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Protein Kinase Inhibitors; Quinazolines; Survival Rate; Thiophenes

2006

Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth.

The Journal of biological chemistry, 2007, Feb-09, Volume: 282, Issue:6

Topics: Amino Acid Substitution; Animals; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Enzyme Activation; Erlotinib Hydrochloride; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Janus Kinase 2; Jurkat Cells; Mice; Phenylalanine; Polycythemia Vera; Protein Kinase Inhibitors; Quinazolines; Valine

2007